What is the average shipment value for India to Malaysia pharmaceutical trade?

$39.9K per consignment across 369 shipments.

How many Indian pharmaceutical companies export to Malaysia?

54 Indian companies. Largest: B BRAUN MEDICAL INDUSTRIES SDN BHD with $10.1M.

How can I find verified Indian pharmaceutical suppliers for Malaysia?

TransData Nexus covers 54 active exporters with shipment history and trade values at transdatanexus.com.

Malaysia to India Pharmaceutical Import (2026) — $14.7M, 54 Foreign Suppliers | TransData Nexus

Malaysia to India Pharmaceutical Import (2026) — $14.7M, 54 Foreign Suppliers | TransData Nexus | TransData Nexus

Top Pharmaceutical Formulations — Malaysia to India

#	Formulation	Value	Share
1	Plasma	$10.5M	71.4%
2	Insulin	$3.9M	26.5%
3	Metformin	$247.6K	1.7%
4	Valsartan	$9.7K	0.1%
5	Sitagliptin	$6.8K	0.0%
6	Apixaban	$5.6K	0.0%
7	Amlodipine	$4.6K	0.0%
8	Hydrochlorothiazide	$3.3K	0.0%
9	Enalapril	$3.3K	0.0%
10	Bisoprolol	$3.2K	0.0%
11	Sodium	$3.0K	0.0%
12	Rivaroxaban	$2.7K	0.0%
13	Vildagliptin	$2.2K	0.0%
14	Dolutegravir	$2.1K	0.0%
15	Ceftazidime	$1.8K	0.0%

India imports 20+ pharmaceutical formulations from Malaysia with a combined trade value of $14.7M. Key products include Plasma ($10.5M), Insulin ($3.9M), Metformin ($248K), Valsartan ($10K), Sitagliptin ($7K). These are finished dosage forms — tablets, capsules, injectables, and combination drugs — shipped from Indian manufacturing facilities with FDA, WHO-GMP, and EU GMP certifications. Data from 369 verified Indian Customs (DGFT) shipment records.

Top Pharmaceutical Products — Malaysia to India Trade Routes

1Plasma$10.5M

2Insulin$3.9M

3Metformin$248K

4Valsartan$10K

5Sitagliptin$7K

6Apixaban

Top Malaysia Suppliers to India

1B Braun Medical Industries Sdn Bhd

$10.1M

2Biocon Sdn Bhd

$3.0M

3Xxocoxxsdnxxhd

$951K

4B Braun Medical Industries Sdn. Bhd.

$386K

5Duopharma (m) Sdn Bhd

$240K

Trade Statistics

Total Value$14.7M

Shipments369

Indian Exporters54

Malaysia Buyers49

Avg Shipment$40K

Products47

Other Import Origins

United States$2.7B Germany$929.2M China$767.5M Italy

Last updated: March 28, 2026

What is the total value of India's pharmaceutical export to Malaysia?

India exported pharmaceuticals worth $14.7M to Malaysia across 369 verified shipments.

Who are the top Indian pharmaceutical exporters to Malaysia?

1. B BRAUN MEDICAL INDUSTRIES SDN BHD — $10.1M. 2. BIOCON SDN BHD — $3.0M. 3. XXOCOXXSDNXXHD — $950.6K. Total: 54 suppliers.

Which companies in Malaysia import pharmaceuticals from India?

1. B BRAUN MEDICAL INDIA PRIVATE LIMITED — $10.1M. 2. BIOCON BIOLOGICS LIMITED — $2.3M. 3. BIOCON BIOLOGICS INDIA LIMITED — $1.6M. 49 buyers total.

What pharmaceutical products does India export most to Malaysia?

1. Plasma ($10.5M, 71.4%); 2. Insulin ($3.9M, 26.5%); 3. Metformin ($247.6K, 1.7%); 4. Valsartan ($9.7K, 0.1%); 5. Sitagliptin ($6.8K, 0.0%)

Which ports handle pharmaceutical shipments from India to Malaysia?

Export: . Import: .

Why does Malaysia import pharmaceuticals from India?

India's cost-competitive generic drug manufacturing, WHO-GMP certified facilities, and broad product portfolio. This $14.7M corridor reflects quality compliance and pricing advantages.

What certifications do Indian pharmaceutical exporters need to supply Malaysia?

WHO-GMP certification, EU GMP approval (for EU markets), product dossier registration (CTD format), and ICH guideline compliance.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Data Source: Indian Customs (DGFT) export shipping bill records covering all pharmaceutical shipments from India.
2.Country Matching: Shipments to Malaysia identified using destination country codes from customs declarations.
3.Statistical Normalization: Values are statistically normalized to remove outlier transactions and ensure accurate market share representation.
4.Coverage: 369 verified shipments from 54 Indian exporters to 49 Malaysia buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

54 Exporters

49 buyers tracked

Expert-Reviewed

By pharmaceutical trade specialists

Malaysia to India Pharmaceutical Import